日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis.

cGAS-IFN-I 通过核胞吞作用从垂死细胞中提取核 DNA 来产生反应。

Negishi Hideo, Wada Yusuke, Shirasaki Yoshitaka, Hayashi Tomoya, Kubota Yuji, Iwasaki Tomio, Kurosawa Mina, Ban Tatsuma, Muto Daisuke, Suenaga Yusuke, Kojima Taichi, Matsuda Yuzuki, Irish Sean Lord, Dodo Kosuke, Suzuki Toru, Yamagishi Mai, Temizoz Burcu, Yoshimori Atsushi, Kanai Chisato, Nagasaki Yoji, Ohmuraya Masaki, Tamura Tomohiko, Iwama Atsushi, Inada Toshifumi, Kuroda Etsushi, Kobiyama Kouji, Toyama-Sorimachi Noriko, Takekawa Mutsuhiro, Coban Cevayir, Ishii Ken J

Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpox

LC16m8疫苗的免疫学分析:对脓痘病毒的临床前和早期临床研究进展

Kouji Kobiyama ,Daichi Utsumi ,Yu Kaku ,Eita Sasaki ,Fumihiko Yasui ,Tomotaka Okamura ,Taishi Onodera ,Asuka Joy Tobuse ,Areej Sakkour ,Ahmad Faisal Amiry ,Tomoya Hayashi ,Burcu Temizoz ,Kaiwen Liu ,Hideo Negishi ,Noriko Toyama-Sorimachi ,Michinori Kohara ,Tatsuya Sawasaki ,Junichi Takagi ,Kei Sato ,Yoshimasa Takahashi ,Yasuhiro Yasutomi ,Ken J Ishii

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

5,6-二甲基黄酮-4-乙酸 (DMXAA) 是一种 STING 部分激动剂,可竞争人类 STING 激活

Burcu Temizoz #, Takayuki Shibahara #, Kou Hioki, Tomoya Hayashi, Kouji Kobiyama, Michelle Sue Jann Lee, Naz Surucu, Erdal Sag, Atsushi Kumanogoh, Masahiro Yamamoto, Mayda Gursel, Seza Ozen, Etsushi Kuroda, Cevayir Coban, Ken J Ishii

TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model

TLR9联合STING激动剂佐剂可诱导强效新肽T细胞免疫,并提高肿瘤模型中免疫检查点阻断的疗效

Melisa D Castro Eiro ,Kou Hioki ,Ling Li ,Merel E P Wilmsen ,Caoimhe H Kiernan ,Inge Brouwers-Haspels ,Marjan van Meurs ,Manzhi Zhao ,Harm de Wit ,Dwin G B Grashof ,Harmen J G van de Werken ,Yvonne M Mueller ,Christopher Schliehe ,Burcu Temizoz ,Kouji Kobiyama ,Ken J Ishii ,Peter D Katsikis

B cell-intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice

B细胞内在的TBK1对于小鼠感染和疫苗接种过程中生发中心的形成至关重要。

Lee, Michelle S J; Inoue, Takeshi; Ise, Wataru; Matsuo-Dapaah, Julia; Wing, James B; Temizoz, Burcu; Kobiyama, Kouji; Hayashi, Tomoya; Patil, Ashwini; Sakaguchi, Shimon; Simon, A Katharina; Bezbradica, Jelena S; Nagatoishi, Satoru; Tsumoto, Kouhei; Inoue, Jun-Ichiro; Akira, Shizuo; Kurosaki, Tomohiro; Ishii, Ken J; Coban, Cevayir

Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants

利用机器学习辅助筛选草药提取物作为疫苗佐剂

Hioki, Kou; Hayashi, Tomoya; Natsume-Kitatani, Yayoi; Kobiyama, Kouji; Temizoz, Burcu; Negishi, Hideo; Kawakami, Hitomi; Fuchino, Hiroyuki; Kuroda, Etsushi; Coban, Cevayir; Kawahara, Nobuo; Ishii, Ken J

CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study

CpG ODN (K3)-Toll样受体9激动剂诱导Th1型免疫反应并增强晚期肺癌患者的细胞毒活性:一项I期研究

Otsuka, Tomoyuki; Nishida, Sumiyuki; Shibahara, Takayuki; Temizoz, Burcu; Hamaguchi, Masanari; Shiroyama, Takayuki; Kimura, Keiko; Miyake, Kotaro; Hirata, Haruhiko; Mizuno, Yumiko; Yagita, Mayu; Manabe, Yusuke; Kuroda, Etsushi; Takeda, Yoshito; Kida, Hiroshi; Ishii, Ken J; Kumanogoh, Atsushi

Vaccine adjuvants as potential cancer immunotherapeutics

疫苗佐剂作为潜在的癌症免疫疗法

Temizoz, Burcu; Kuroda, Etsushi; Ishii, Ken J

Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells

循环纳米颗粒TLR9激动剂可探测肿瘤微环境,释放具有免疫原性的死亡肿瘤细胞。

Kitahata, Yuji; Kanuma, Tomohiro; Hayashi, Masayuki; Kobayashi, Nobuyoshi; Ozasa, Koji; Kusakabe, Takato; Temizoz, Burcu; Kuroda, Etsushi; Yamaue, Hiroki; Coban, Cevayir; Yamamoto, Takuya; Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN

TLR9 和 STING 激动剂协同诱导先天性和适应性 II 型干扰素

Temizoz, Burcu; Kuroda, Etsushi; Ohata, Keiichi; Jounai, Nao; Ozasa, Koji; Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J